Su ZG - Search Results

1

Light-Induced ROS Generation and 2-DG-Activated Endoplasmic Reticulum Stress by Antitumor Nanosystems: An Effective Combination Therapy by Regulating the Tumor Microenvironment.

Dong M, Xiao XZ, Su ZG, Yu ZH, Qian CG, Liu JH, Zhao JC, Shen QD. Dong M, et al. Among authors: su zg. Small. 2019 Apr;15(17):e1900212. doi: 10.1002/smll.201900212. Epub 2019 Apr 3. Small. 2019. PMID: 30941900

2

ROS-triggered and regenerating anticancer nanosystem: an effective strategy to subdue tumor's multidrug resistance.

Su Z, Chen M, Xiao Y, Sun M, Zong L, Asghar S, Dong M, Li H, Ping Q, Zhang C. Su Z, et al. J Control Release. 2014 Dec 28;196:370-83. doi: 10.1016/j.jconrel.2014.09.020. Epub 2014 Sep 30. J Control Release. 2014. PMID: 25278256

3

Nano-sponge-like liposomes remove cholesterol crystals for antiatherosclerosis.

Gong F, Wang Z, Mo R, Wang Y, Su J, Li X, Omonova CTQ, Khamis AM, Zhang Q, Dong M, Su Z. Gong F, et al. J Control Release. 2022 Sep;349:940-953. doi: 10.1016/j.jconrel.2022.07.021. Epub 2022 Aug 9. J Control Release. 2022. PMID: 35870569

4

An elastase-inhibiting, plaque-targeting and neutrophil-hitchhiking liposome against atherosclerosis.

Shi Y, Dong M, Wu Y, Gong F, Wang Z, Xue L, Su Z. Shi Y, et al. Acta Biomater. 2024 Jan 1;173:470-481. doi: 10.1016/j.actbio.2023.11.020. Epub 2023 Nov 19. Acta Biomater. 2024. PMID: 37984628

5

Transforming Weakness into Strength: Photothermal-Therapy-Induced Inflammation Enhanced Cytopharmaceutical Chemotherapy as a Combination Anticancer Treatment.

Zhang L, Zhang Y, Xue Y, Wu Y, Wang Q, Xue L, Su Z, Zhang C. Zhang L, et al. Adv Mater. 2019 Feb;31(5):e1805936. doi: 10.1002/adma.201805936. Epub 2018 Dec 9. Adv Mater. 2019. PMID: 30537012

6

The Impaired Mechanism and Facilitated Therapies of Efferocytosis in Atherosclerosis.

Wang Z, Su J, Gong F, Xue L, Su Z. Wang Z, et al. J Cardiovasc Pharmacol. 2022 Sep 1;80(3):407-416. doi: 10.1097/FJC.0000000000001311. J Cardiovasc Pharmacol. 2022. PMID: 35853202 Review.

7

Effect of octreotide surface density on receptor-mediated endocytosis in vitro and anticancer efficacy of modified nanocarrier in vivo after optimization.

Su Z, Shi Y, Xiao Y, Sun M, Ping Q, Zong L, Li S, Niu J, Huang A, You W, Chen Y, Chen X, Fei J, Tian J. Su Z, et al. Int J Pharm. 2013 Apr 15;447(1-2):281-92. doi: 10.1016/j.ijpharm.2013.01.068. Epub 2013 Feb 7. Int J Pharm. 2013. PMID: 23396258

8

A Collaborative Assembly Strategy for Tumor-Targeted siRNA Delivery.

Sun Q, Kang Z, Xue L, Shang Y, Su Z, Sun H, Ping Q, Mo R, Zhang C. Sun Q, et al. J Am Chem Soc. 2015 May 13;137(18):6000-10. doi: 10.1021/jacs.5b01435. Epub 2015 May 4. J Am Chem Soc. 2015. PMID: 25869911

9

Mitoxantrone- and Folate-TPGS2k Conjugate Hybrid Micellar Aggregates To Circumvent Toxicity and Enhance Efficiency for Breast Cancer Therapy.

Guissi NE, Li H, Xu Y, Semcheddine F, Chen M, Su Z, Ping Q. Guissi NE, et al. Mol Pharm. 2017 Apr 3;14(4):1082-1094. doi: 10.1021/acs.molpharmaceut.6b01009. Epub 2017 Feb 24. Mol Pharm. 2017. PMID: 28191959

10

Folate Receptor-Targeting and Reactive Oxygen Species-Responsive Liposomal Formulation of Methotrexate for Treatment of Rheumatoid Arthritis.

Chen M, Amerigos J C KD, Su Z, Guissi NEI, Xiao Y, Zong L, Ping Q. Chen M, et al. Pharmaceutics. 2019 Nov 6;11(11):582. doi: 10.3390/pharmaceutics11110582. Pharmaceutics. 2019. PMID: 31698794 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters